Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Background/Aims: Patients with various chronic liver diseases frequently have increased body iron stores. Prohepcidin is an easily measurable precursor of hepcidin, which is a key regulator of iron homeostasis. This study investigated the serum prohepcidin levels in patients with various chronic liver diseases with various etiologies. Methods: Serum prohepcidin levels were measured in patients with chronic hepatitis C (CH-C) (n=28), nonalcoholic fatty liver disease (NAFLD) (n=24), and alcoholic liver disease (ALD) (n=22), and in healthy controls (n=25) using commercial ELISA. Serum interleukin 6 (IL-6) levels and blood iron indices were also measured. Results: The serum levels of both prohepcidin and IL-6 were significantly higher in CH-C patients than in healthy controls, and there was a positive correlation between the IL-6 and prohepcidin levels (r=0.505, p=0.020). The prohepcidin levels in ALD patients did not differ from those in controls, despite their significantly elevated IL-6 levels. There was a tendency for a negative correlation between serum prohepcidin levels and transferrin saturation in ALD patients (r=-0.420, p=0.051). Neither prohepcidin nor IL-6 was significantly elevated in the NAFLD group, despite the presence of elevated serum iron and ferritin levels. Conclusions: The role of prohepcidin may differ in different human liver diseases. In the setting of CH-C, both the serum prohepcidin and IL-6 levels were significantly elevated and were positively correlated with each other.
Abstract
Background/Aims: Patients with various chronic liver diseases frequently have increased body iron stores. Prohepcidin is an easily measurable precursor of hepcidin, which is a key regulator of iron homeostasis. This study investigated the serum prohepcidin levels in patients with various chronic liver diseases with various etiologies. Methods: Serum prohepcidin levels were measured in patients with chronic hepatitis C (CH-C) (n=28), nonalcoholic fatty liver disease (NAFLD) (n=24), and alcoholic liver disease (ALD) (n=22), and in healthy controls (n=25) using commercial ELISA. Serum interleukin 6 (IL-6) levels and blood iron indices were also measured. Results: The serum levels of both prohepcidin and IL-6 were significantly higher in CH-C patients than in healthy controls, and there was a positive correlation between the IL-6 and prohepcidin levels (r=0.505, p=0.020). The prohepcidin levels in ALD patients did not differ from those in controls, despite their significantly elevated IL-6 levels. There was a tendency for a negative correlation between serum prohepcidin levels and transferrin saturation in ALD patients (r=-0.420, p=0.051). Neither prohepcidin nor IL-6 was significantly elevated in the NAFLD group, despite the presence of elevated serum iron and ferritin levels. Conclusions: The role of prohepcidin may differ in different human liver diseases. In the setting of CH-C, both the serum prohepcidin and IL-6 levels were significantly elevated and were positively correlated with each other.
참고문헌 (35)
- Hentze MW, "Balancing acts: molecular control of mammalian iron metabolism", Cell, 117, pp.285~297 (2004)
- Fleming RE, "Orchestration of iron homeostasis", N Engl J Med, 352, pp.1741~1744 (2005)
- Di Bisceglie AM, "Measurements of iron status in patients with chronic hepatitis", Gastroenterology, 102, pp.2108~2113 (1992)
- Boucher E, "Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment", Gut, 41, pp.115~120 (1997)
- Metwally MA, "Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection", Am J Gastroenterol, 99, pp.286~291 (2004)
- Shan Y, "Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey", Clin Infect Dis, 40, pp.834~841 (2005)
- Kohgo Y, "Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis", insulin resistance, 2007, pp.13, 4699~4706
- Bell H, "Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases", J Intern Med, 236, pp.315~322 (1994)
- Kohgo Y, "Iron accumulation in alcoholic liver diseases", Alcohol Clin Exp Res, 29, pp.189S~193S (2005)
- Bonkovsky HL, "Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis", J Hepatol, 31, pp.421~429 (1999)
- Krause A, "LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity", FEBS Lett, 480, pp.147~150 (2000)
- Park CH, "Hepcidin, a urinary antimicrobial peptide synthesized in the liver", J Biol Chem, 276, pp.7806~7810 (2001)
- Pigeon C, "A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload", J Biol Chem, 276, pp.7811~7819 (2001)
- Ganz T, "Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation", Blood, 102, pp.783~788 (2003)
- Nemeth E, "Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization", Science, 306, pp.2090~2093 (2004)
- Nicolas G, "iron overload in upstream stimulatory factor 2 (USF2) knockout mice", Proc Natl Acad Sci U.S.A, 98, pp.8780~8785 (2001)
- Laftah AH, "Effect of hepcidin on intestinal iron absorption in mice", Blood, 103, pp.3940~3944 (2004)
- Nemeth E, "Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein", Blood, 101, pp.2461~2463 (2003)
- Kulaksiz H, "Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia", Gut, 53, pp.735~743 (2004)
- Lee SH, "HFE gene mutations, serum ferritin level, transferrin saturation, and their clinical correlates in a Korean population", Dig Dis Sci, 54, pp.879~886 (2009)
- 정자용, "여대생에서 혈청 pro-hepcidin 농도와 철분 영양 상태와의 관계", 한국영양학회지, 38(9), pp.750~755 (2005), 한국영양학회
- Luukkonen S, "Serum pro-hepcidin concentrations and their responses to oral iron supplementation in healthy subjects manifest considerable inter-individual variation", Clin Chem Lab Med, 44, pp.1361~1362 (2006)
- Nagashima M, "Regulatory failure of serum prohepcidin levels in patients with hepatitis C", Hepatol Res, 36, pp.288~293 (2006)
- Aoki CA, "Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C", J Clin Gastroenterol, 39, pp.71~74 (2005)
- Migita K, "Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection", Hum Immunol, 67, pp.27~32 (2006)
- Machida K, "Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6", J Virol, 80, pp.866~874 (2006)
- Feldmann G, "Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma", Clin Cancer Res, 12, pp.4491~4498 (2006)
- Nemeth E, "IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin", J Clin Invest, 113, pp.1271~1276 (2004)
- Nishina S, "Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription", Gastroenterology, 134, pp.226~238 (2008)
- Bridle K, "Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease", Alcohol Clin Exp Res, 30, pp.106~112 (2006)
- Harrison-Findik DD, "Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression", J Biol Chem, 281, pp.22974~22982 (2006)
- Ohtake T, "Hepcidin is down-regulated in alcohol loading", Alcohol Clin Exp Res, 31, pp.S2~S8 (2007)
- Nicolaou C, "Serum cytokine concentrations in alcohol-dependent individuals without liver disease", Alcohol, 32, pp.243~247 (2004)
- Bekri S, "Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH", Gastroenterology, 131, pp.788~796 (2006)
- Barisani D, "Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload", J Hepatol, 49, pp.123~133 (2008)
